Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery

June 1, 2026 updated by: Duke University

Optimizing Recovery in Trauma Patients: Integrating Enhanced Nutrition Delivery With Muscle Assessments, Functional Outcomes and Quality of Life

This is a prospective, randomized, controlled trial designed to evaluate the impact of enhanced protein supplementation compared to a standard of care nutrition delivery in critically ill older adult trauma patients. Subjects will be randomized 1:1 to either enhanced nutrition or control arm. Subjects randomized to the enhanced nutrition arm will receive oral nutrition supplements (ONS) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass.

Study Overview

Detailed Description

This is a prospective, randomized, controlled trial designed to evaluate the impact of enhanced protein supplementation compared to a standard of care nutrition delivery in critically ill older adult trauma patients. Enhanced protein supplementation supports patients from ICU admission to 4-weeks post-hospital discharge, providing a comprehensive and personalized plan of care carried to completion.

Subjects will be randomized 1:1 to enhanced nutrition or control arm. Subjects randomized enhanced nutrition oral nutrition supplements (Fresenius KCAL shakes) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers.

Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass. They will also be asked to complete walking and strength tests, and surveys about quality of life.These will be done at hospital admission, day 14 or hospital discharge, and at a one month post-discharge follow-up visit.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Recruiting
        • Duke University Hospital
        • Contact:
        • Sub-Investigator:
          • Krista Haines, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients who are at least 45 years old and presented to the Emergency Department as a leveled trauma
  • Patients who have the ability to tolerate oral nutrition
  • Patients who have had a standard of care CT scan this admission

Exclusion Criteria:

  • Expected withdrawal of life-sustaining treatment within 48 hours
  • Traumatic Brain Injury
  • Presence of lower extremity fracture(s)
  • Mechanical Ventilation
  • Subjects for who the Investigator would recommend a different supplement based on their medical condition.
  • Prisoner
  • Pregnancy for women of child-bearing potential

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Enhanced Protein Supplementation
Oral nutrition supplements (ONS) will be given, at maximum, three times per day throughout hospitalization. Upon discharge, participants will be given 4-weeks' worth of oral supplements to take. Adjustments may be made based on indirect calorimetry (IC) measurements.
Fresubin drinks will be taken up to 3 times a day throughout hospitalization and for 4 weeks after discharge.
No Intervention: Control Pathway
Standard of care nutrition delivery throughout hospitalization. Upon discharge participants will be sent home with standard nutrition information without Indirect Calorimetry (IC) guidance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle mass as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
Baseline to one month post-discharge (approximately six weeks)
Change in glycogen stores as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
Baseline to one month post-discharge (approximately six weeks)
Change in body composition (percentage of a body's weight that is fat tissue) as a measure of muscle quality
Time Frame: Baseline to one month post-discharge (approximately six weeks)
Body composition is the percentage of a body's weight that is fat tissue.
Baseline to one month post-discharge (approximately six weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in six minute walk test (6MWT) distance
Time Frame: Baseline to one month post-discharge (approximately six weeks)
The 6MWT assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
Baseline to one month post-discharge (approximately six weeks)
Change in four meter gait speed
Time Frame: Baseline to one month post-discharge (approximately six weeks)
Four meter gait speed is the time one takes to walk four meters on a level surface.
Baseline to one month post-discharge (approximately six weeks)
Change in 30-second sit to stand test
Time Frame: Baseline to one month post-discharge (approximately six weeks)
This test measures the number of times an individual can stand from a chair with no assistance in 30 seconds. This test is used to assess functional lower body strength.
Baseline to one month post-discharge (approximately six weeks)
Change in grip strength
Time Frame: Baseline to one month post-discharge (approximately six weeks)
Grip strength is a measure of muscular strength or the maximum force/tension generated by one's forearm muscles. It can be used as a screening tool for the measurement of upper body strength and overall strength.
Baseline to one month post-discharge (approximately six weeks)
Change in quadriceps strength
Time Frame: Baseline to one month post-discharge (approximately six weeks)
ED (electromechanical dynamometry) can be used in either isometric or isokinetic mode. Quadriceps strength is expressed as peak knee extensor torque, which is produced at around 60° knee flexion.
Baseline to one month post-discharge (approximately six weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Paul Wischmeyer, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2026

Primary Completion (Estimated)

May 30, 2028

Study Completion (Estimated)

May 30, 2028

Study Registration Dates

First Submitted

May 3, 2024

First Submitted That Met QC Criteria

July 22, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Nutrition Supplements - Fresubin KCAL Drinks

Subscribe